about
Through the looking glass, mechanistic insights from enantiomeric human defensinsSystematic Mutational Analysis of Peptide Inhibition of the p53–MDM2/MDMX InteractionsD-peptide inhibitors of the p53–MDM2 interaction for targeted molecular therapy of malignant neoplasmsPharmacokinetics of timolol in aqueous humor sampled by microdialysis after topical administration of thermosetting gels.Sustained intravitreal delivery of dexamethasone using an injectable and biodegradable thermogel.In vivo retention of poloxamer-based in situ hydrogels for vaginal application in mouse and rat models.Amino-functionalized poloxamer 407 with both mucoadhesive and thermosensitive properties: preparation, characterization and application in a vaginal drug delivery system.Facile Noninvasive Retinal Gene Delivery Enabled by Penetratin.Effect of carrageenan on poloxamer-based in situ gel for vaginal use: Improved in vitro and in vivo sustained-release properties.Penetratin, a potentially powerful absorption enhancer for noninvasive intraocular drug delivery.Functionalized cell nucleus-penetrating peptide combined with doxorubicin for synergistic treatment of glioma.A novel penetratin-modified complex for noninvasive intraocular delivery of antisense oligonucleotides.Discerning the composition of penetratin for safe penetration from cornea to retina.Noninvasive delivery of oligonucleotide by penetratin-modified polyplexes to inhibit protein expression of intraocular tumor.Stabilization of recombinant human growth hormone against emulsification-induced aggregation by Pluronic surfactants during microencapsulation.Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin.In vivo hepatocellular expression of interleukin-22 using penetratin-based hybrid nanoparticles as potential anti-hepatitis therapeuticsEnhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical CancerA novel nanoscale-dispersed eye ointment for the treatment of dry eye diseaseCell-permeable NF-κB inhibitor-conjugated liposomes for treatment of gliomaOctopus-like Flexible Vector for Noninvasive Intraocular Delivery of Short Interfering Nucleic AcidsIn-Vivo Toxicity Studies and In-Vitro Inactivation of SARS-CoV-2 by Povidone-iodine In-situ Gel Forming Formulations
P50
Q24652382-D4C36A20-65E2-4055-88A3-1FE5A9BBEDA0Q27660219-C9F2BDD0-F2A9-4D36-89E5-E24C94FE3445Q27663612-843FEB3C-A890-4915-8760-74C291825D67Q33217055-10B09781-B2CF-42C2-AC6A-34B3E4168398Q40907583-0DBDB767-837E-4531-A883-E55201804377Q41068671-80AB343B-6E1F-4D27-850D-E32809C221F8Q41231571-FF70667E-6BE8-41CF-8511-CC1B8F19C28AQ45856130-B897C034-A9F0-420D-BB8E-A9AD31987D86Q45985479-4E2129E3-956A-4AE8-A441-AC0BA56DCCDDQ46249056-3DF1CD4C-826E-4A7D-8FD5-91E2A92D6C01Q48643987-FBF1B7DD-6FC4-40E5-8DBB-7B08235FA065Q48734177-FDEBBE2B-0618-458A-834F-86DAF912AD14Q50014167-FB49E760-2965-413B-A32A-6BAF131314E2Q50654093-755FDEEB-7F66-403C-BE92-B4E25EA794DFQ51056117-C0EC0426-509A-42A5-A442-D2FBE9E83F6CQ51821579-DCAEAF1A-EB01-4C5C-9551-5E921A947081Q57188237-5A1C8C4F-034E-4CA9-A30D-C75D6BA52CFBQ61806413-F185BCFA-6BD0-4676-99F2-8F936898B833Q87363057-F67D07EE-C3F6-4524-947D-66B389EAB781Q91652906-AAF47EDF-925F-4DDE-8294-ABEB45EB9EEEQ92817191-542AC897-C6A0-40AB-9B74-30BF7EB90CC5Q95603114-3A6DAA8E-CEB2-4A3A-82AA-52AF4F707986
P50
description
investigador
@es
researcher
@en
name
Gang Wei
@en
Gang Wei
@nl
type
label
Gang Wei
@en
Gang Wei
@nl
prefLabel
Gang Wei
@en
Gang Wei
@nl
P31
P496
0000-0002-9600-0982